Authors: |
Guedj, J; Dahari, H; Uprichard, S. L.; Perelson, A. S. |
Article Title: |
The hepatitis C virus NS5A inhibitor daclatasvir has a dual mode of action and leads to a new virus half-life estimate |
Journal Title: |
Expert review of gastroenterology hepatology
|
Volume: |
7 |
Issue: |
5 |
ISSN: |
1747-4132; 1747-4124 |
Publisher: |
Unknown
|
Journal Place: |
England |
Date Published: |
2013 |
Start Page: |
397 |
End Page: |
399 |
Language: |
eng |
DOI/URL: |
|
Notes: |
LR: 20150417; GR: AI028433/AI/NIAID NIH HHS/United States; GR: HL109334/HL/NHLBI NIH HHS/United States; GR: OD011095/OD/NIH HHS/United States; GR: P20-GM103452/GM/NIGMS NIH HHS/United States; GR: R01 AI028433/AI/NIAID NIH HHS/United States; GR: R01 AI078881/AI/NIAID NIH HHS/United States; GR: R01 OD011095/OD/NIH HHS/United States; GR: R56/R01-AI078881/AI/NIAID NIH HHS/United States; JID: 101278199; 0 (Antiviral Agents); 0 (BMS-790052); 0 (Enzyme Inhibitors); 0 (Imidazoles); 0 (NS-5 protein, hepatitis C virus); 0 (Viral Nonstructural Proteins); NIHMS585897; OID: NLM: NIHMS585897; OID: NLM: PMC4067513; ppublish |